Celcuity Inc.
(NASDAQ : CELC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
CPRTCopart, Inc.
-6.33%52.584.5%$126.59m
ETSYEtsy, Inc.
-2.48%47.547.9%$117.98m
EFXEquifax Inc.
-0.08%133.422.0%$97.37m
BZUNBaozun Inc Sponsored ADR Class A
0.77%48.591.7%$96.17m
FLTFleetCor Technologies, Inc.
0.06%222.323.4%$95.43m
ULTIUltimate Software Group, Inc.
-0.55%312.619.9%$82.07m
CTASCintas Corporation
0.01%211.704.5%$77.44m
ITGartner, Inc.
0.99%158.462.4%$75.73m
ZZillow Group, Inc. Class C
-4.16%42.8110.3%$74.69m
TRUTransUnion
-1.58%74.330.9%$73.31m
XRXXerox Corporation
-1.72%28.005.3%$70.42m
RLGYRealogy Holdings Corp.
-0.07%20.593.4%$64.89m
CDKCDK Global Inc
0.51%63.172.2%$57.86m
PRAHPRA Health Sciences, Inc.
-0.64%107.782.4%$48.20m
BAHBooz Allen Hamilton Holding Corporation Class A
-0.30%49.581.9%$42.74m

Company Profile

Celcuity, Inc. is cellular analysis company that is discovering new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. Its proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded in January 2012 by Brian Sullivan and Lance Laing and is headquartered in Minneapolis, MN.